Semaglutide vs AOD-9604: A Fat Loss Peptide Comparison
Table of Contents
Quick Comparison Table
| Feature | Semaglutide | AOD-9604 |
|---|---|---|
| Class | GLP-1 receptor agonist | Modified HGH fragment (176-191) |
| Mechanism | Appetite suppression, insulin regulation | Lipolysis stimulation, lipogenesis inhibition |
| Clinical Evidence | Extensive (Phase III trials, FDA-approved) | Limited (Phase II, mixed results) |
| Average Weight Loss | 15-17% body weight | Modest in clinical trials |
| Administration | Weekly injection or oral | Daily subcutaneous injection |
| Side Effects | GI issues (nausea, vomiting) | Generally mild |
How Semaglutide Works
Semaglutide activates GLP-1 receptors in the brain and gut, producing powerful appetite suppression, delayed gastric emptying, and improved insulin signaling. The STEP clinical trials demonstrated consistent 15-17% body weight reduction, making it one of the most effective pharmaceutical weight loss tools ever studied.
Its effects extend beyond fat loss — semaglutide shows cardiovascular benefits, reduced inflammation, and improved metabolic markers across multiple trials.
How AOD-9604 Works
AOD-9604 is a modified fragment of human growth hormone (amino acids 176-191) designed to isolate HGH's fat-burning properties without its growth-promoting or diabetogenic effects. It works by:
- Stimulating lipolysis (fat breakdown) in adipose tissue
- Inhibiting lipogenesis (new fat formation)
- Acting without affecting blood sugar or IGF-1 levels
While the mechanism is sound, clinical trials produced mixed results, and AOD-9604 has not achieved FDA approval for weight loss.
Head-to-Head Differences
Efficacy: Semaglutide produces dramatically greater weight loss in clinical studies. AOD-9604 showed modest fat reduction in early trials but failed to demonstrate strong efficacy in Phase II/III.
Mechanism: Semaglutide primarily works through appetite suppression (central nervous system). AOD-9604 works peripherally on fat tissue. They target completely different pathways.
Side effects: Semaglutide's GI side effects (nausea, vomiting) are significant for some users. AOD-9604 is generally well-tolerated with minimal side effects.
Evidence quality: Semaglutide is backed by some of the largest obesity trials ever conducted. AOD-9604's evidence base is considerably thinner.
Which Should You Choose?
For maximum evidence-backed fat loss, semaglutide is clearly superior. For researchers interested in peripheral fat metabolism without appetite or blood sugar effects, AOD-9604 offers a unique mechanism worth studying. Some researchers investigate both as complementary approaches.
Where to Source Research Peptides
Research-grade semaglutide and AOD-9604 are available from Ascension Peptides, with third-party testing and certificates of analysis included with every order.
Looking for Quality Peptides?
If you're researching peptides, quality sourcing matters. Ascension Peptides offers 99%+ purity with third-party COA testing on every batch.
Explore Ascension Peptides →Affiliate link — we may earn a commission at no extra cost to you
Frequently Asked Questions
Is AOD-9604 as effective as semaglutide for weight loss?
Can semaglutide and AOD-9604 be combined?
Does AOD-9604 affect blood sugar?
Why is AOD-9604 still popular despite weak clinical data?
Related Peptides
🔬 Looking for quality peptides?
Only buy from suppliers with third-party COA testing.
Ascension Peptides — Verified Supplier →Affiliate link — we may earn a commission.